Table 1.
Overall survival (n = 237) | ||||
---|---|---|---|---|
Variables | Univariable (HR, 95%CI) | P | Multivariable (HR, 95%CI) | P |
Age | ||||
<67 | 1 | NA | 1 | NA |
≥67 | 1.47 (0.97–2.23) | 0.069 | 1.43 (0.92–2.19) | 0.111 |
Gender | ||||
Female | 1 | NA | 1 | NA |
Male | 1.05 (0.69–1.60) | 0.827 | 1.74 (1.06–2.86) | 0.029 |
pT | ||||
T1-T2 | 1 | NA | 1 | NA |
T3-T4 | 2.74 (1.79–4.17) | <0.001 | 1.08 (0.46–2.55) | 0.853 |
pN | ||||
N0 | 1 | NA | 1 | NA |
N1 | 2.95 (1.52–5.71) | <0.001 | 1.33 (0.65–2.71) | 0.437 |
pM | ||||
M0 | 1 | NA | 1 | NA |
M1 | 3.81 (2.46–5.92) | <0.001 | 2.55 (1.50–4.32) | <0.001 |
Stage | ||||
I-II | 1 | NA | 1 | NA |
III-IV | 3.10 (1.99–4.81) | <0.001 | 1.53 (0.59–3.95) | 0.377 |
Grade | ||||
I-II | 1 | NA | 1 | NA |
III-IV | 2.47 (1.56–3.92) | <0.001 | 1.74 (1.06–2.86) | 0.029 |
miR-25/IMPA2 levels | ||||
Low/high | 1 | NA | 1 | NA |
High/low | 3.22 (1.75–5.95) | <0.001 | 2.43 (1.21–4.91) | 0.013 |
HR and CI denote hazard ratio and confident interval, respectively.